Showing results (601-610 of 791) with videos related to

Sort By:
Pageof 80
JAMA Network Open|May 14, 2026
Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy IndividualsRebecca Z Rousset, Madison I J Honey, Anouk den Braber, et al.
Neurology|September 29, 2012
Injury markers predict time to dementia in subjects with MCI and amyloid pathologyIneke A van Rossum, Stephanie J B Vos, Leah Burns, et al.
Journal of Alzheimer'S Disease : JAD|January 17, 2022
Psychosocial Effects of COVID-19 Measures on (Pre-)Dementia Patients During Second LockdownEls D Bakker, Ingrid S van Maurik, Arenda Mank, et al.
Brain : a Journal of Neurology|October 21, 2022
Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's diseaseEllen H Singleton, Jay L P Fieldhouse, Jochum J van 't Hooft, et al.
Neurology|January 27, 2025
Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory ClinicSven J Van Der Lee, Marc Hulsman, Rosalina Van Spaendonk, et al.
Neurobiology of Aging|April 27, 2019
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe projectTessa Timmers, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's diseaseMiriam Rabl, Willem L Hartog, Wiesje M van der Flier, et al.
Nature Communications|September 13, 2023
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s diseaseMarta Del Campo, Lisa Vermunt, Carel F W Peeters, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 8, 2019
Clinician-patient communication during the diagnostic workup: The ABIDE projectLeonie N C Visser, Marleen Kunneman, Laxsini Murugesu, et al.
Pageof 80